FAQ

FREQUENTLY ASKED QUESTIONS

What is Multiplate®?

What anticoagulants can be used with Multiplate® testing?

How is standardization accomplished with the Multiplate® assay?

What are the nominal agonist concentrations of the Multiplate® assay?

Describe the training for Multiplate®.

How are platelets activated?

What is the standard assay?

What variables can be changed in the assay?

How is the data saved?

What is routine maintenance/preventative maintenance?

How extensively has Multiplate® been used?

 


 

What is Multiplate®?

Multiplate® is a 5 channel instrument that measures the platelet aggregation of whole blood by impedance aggregometry.  Each disposable test cell has 2 independent electrode circuits. The instrument software measures the attachment of agonist-activated platelets to the electrode by the change in the electrical impedance at 0.57 second intervals.  The software calculates the average of the two circuits for the aggregation measurement period. The data, after transformation, is in Units (U).  Normal values are approximately between 40 to 125 Units, but the normal range of platelet function varies with the anticoagulant of the whole blood and with the agonist used for platelet activation. Multiplate® is for Research Use Only in the US and Canada.

 


 

What anticoagulants can be used with Multiplate® testing?

The instrument manufacturer has provided research reference ranges for three anticoagulants; lithium heparin (typically a green top blood collection tube), 3.2 % citrate (typically a blue top blood collection tube), and an RUO hirudin blood collection tube (3 ml) available from the instrument manufacturer.  With the hirudin whole blood, the hirudin concentration in whole blood is >15 ug/ml.  Note that the ACD blood collection tube (typically a yellow top blood collection tube) is not suitable for platelet function testing as low pH inhibits platelet function.  Other anticoagulants require user validation for their suitability.

 


 

How is standardization accomplished with the Multiplate® assay?

The test cell has a silver electrode of standardized length/diameter, the nominal assay is performed with defined and controlled time/volume/temperature, and the assay is done with defined agonist concentrations. Testing of a normal individual is not required with each assay.

 


 

What are the nominal agonist concentrations of the Multiplate® assay?

TEST AGONIST REAGENT CONCENTRATION [AGONIST] in
TEST CELL
ADPtest ADP 200 µM 6.5 µM
ADPtest HS ADP + PGE1 200 µM + 300 nM 6.25 µM + 9.4 nM
ASPItest arachidonic aid 15 mM 0.5 mM
COLtest collagen 100 µg/ml 3.2 µg/ml
TRAPtest TRAP-6 peptide 1000 µM 32 µM
RISTOtest ristocetin 10 mg/ml
RISTOlow 0.2 mg/ml
RISTOhigh 0.77 mg/ml
CONTROLS
ASA control acetylsalicylic acid 30 mg/ml 1 mg/ml
GPIIb/IIIa Antagonist synthetic inhibitor 50 µg/ml 1.6 µg/ml

The calculation of agonist concentration in the test cell uses whole blood (WB) volume without consideration that approximately half of WB is red cell volume. Values derived from Multiplate® product literature.

 


 

Describe the training for Multiplate®.

The instrument is very intuitive to use. Instrument setup takes about 2 hours and is performed by a trained individual of Diapharma.  Training include testing of a normal individual, data interpretation, electronic pipette use, how to create a pipette protocol, reagent preparation/use/storage, review of software features, and review of all maintenance activities. Generally a user can perform an assay after 30 minutes of instruction.  Review of all instruments features typically requires 3 to 4 hours.

 


 

How are platelets activated?

Platelets are activated by agonists that are specific to individual receptors of the platelet. With Multiplate®, the standard agonists are ADP, arachidonic acid (AA), collagen, and TRAP (thrombin receptor activating peptide of 6 amino acids).  These agonists bind to their specific receptors; P2Y1/P2Y12, TXA2 receptor after AA conversion by COX-1 to TXA2, GPVI, and PAR-1.

Ristocetin is also used as an agonist, however this produces platelet agglutination rather than aggregation by binding to GPIb/vWF (von Willebrand factor).

The user can test other agonists (e.g., PAR-4 Agonist) and also evaluate the effect of antagonists on platelet function.

 


 

What is the standard assay?

The software-guided pipette prompts the user to add diluent (0.3 ml, 0.9% NaCl or 0.9% NaCl/3 mM CaCl2, agonist specific), whole blood (0.3 ml), and then agonist (0.02 ml) in the nominal three-step assay.  The diluent/whole blood is incubated at 37° C for 3 minutes with stirring and aggregation, also with stirring, is measured for 6 minutes at 37° C in the standard assay for a total assay time of 9 minutes.  (Note that each test cell comes with a PTFE stir bar.)

 


 

What variables can be changed in the assay?

With the preincubation step, there is an opportunity to add three reagents and at the aggregation step, one can add three reagents. Volume can be changed, temperature can be changed to a limited extent, and aggregation time can be measured from 3 to 30 minutes.

Currently a mini test cell is available which uses 0.175 ml diluent/0.175 ml whole blood/0.012 ml agonist to achieve the same concentrations as the standard test cell. The mini test cell can be used for small animal studies or situations where volume is critical. But, here one sees about 25% less aggregation as compared to the standard test cell.

 


 

How is the data saved?

The data is automatically saved as a png file of the assay output (picture) and also as the raw data in aggregation units.  The user can export the data via a flash drive and calculate aggregation for any time period or time segment of interest.  Data is available as the individual assay or as the average of the assay.

 


 

What is routine maintenance/preventative maintenance?

The manufacturer recommends the sensor cables be replaced periodically.  An annual service is available to check the system which includes temperature checks, stirring checks, electronic and liquid control testing.  The electronic pipette is calibrated by the pipette manufacturer minimally on an annual basis.  The Multiplate® system does not require user calibration or adjustments.

 


 

How extensively has Multiplate® been used?

Multiplate® has been available since 2006 and is for Research Use Only in the US and Canada.

The instrument is used for research to assess the effect of antiplatelet drugs — aspirin, thienopyridines, dual antiplatelet therapy, PAR-1 inhibitors and to assess congenital platelet dysfunction. There are over 500 publications to date describing the methodology and its use in platelet testing.